Insider Transactions in Q1 2024 at Cumberland Pharmaceuticals Inc (CPIX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2024
|
Martin S Brown Jr |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+14.29%
|
$1,000
$1.71 P/Share
|
|
Mar 25
2024
|
Caroline Young Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+3.61%
|
$1,000
$1.71 P/Share
|
|
Mar 25
2024
|
Joseph C Galante |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+1.66%
|
$1,000
$1.71 P/Share
|
|
Mar 25
2024
|
James Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+2.91%
|
$1,000
$1.71 P/Share
|
|
Mar 25
2024
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+2.03%
|
$5,000
$1.71 P/Share
|
|
Mar 23
2024
|
Chris T. Bitterman Vice Pres Sales & Marketing |
SELL
Payment of exercise price or tax liability
|
Direct |
593
-11.24%
|
$593
$1.81 P/Share
|
|
Mar 23
2024
|
James L Herman VP and Chief Compliance Office |
SELL
Payment of exercise price or tax liability
|
Direct |
1,186
-3.01%
|
$1,186
$1.81 P/Share
|
|
Mar 23
2024
|
A J Kazimi Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,710
-0.45%
|
$25,710
$1.81 P/Share
|
|
Mar 23
2024
|
John M. Hamm VP Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
445
-1.68%
|
$445
$1.81 P/Share
|
|
Mar 23
2024
|
Todd M. Anthony Vice Pres Organizational Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
816
-4.76%
|
$816
$1.81 P/Share
|